Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 442

1.

Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.

Ikeda-Dantsuji Y, Ohno H, Tanabe K, Umeyama T, Ueno K, Nagi M, Yamagoe S, Kinjo Y, Miyazaki Y.

J Infect Chemother. 2015 Dec;21(12):831-6. doi: 10.1016/j.jiac.2015.08.001. Epub 2015 Oct 23.

PMID:
26477011
2.

The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.

Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ.

MBio. 2012 May 8;3(3). pii: e00103-12. doi: 10.1128/mBio.00103-12. Print 2012.

3.

Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans.

Okubo Y, Wakayama M, Ohno H, Yamamoto S, Tochigi N, Tanabe K, Kaneko Y, Yamagoe S, Umeyama T, Shinozaki M, Nemoto T, Nakayama H, Sasai D, Ishiwatari T, Shimodaira K, Yamamoto Y, Kamei K, Miyazaki Y, Shibuya K.

Jpn J Infect Dis. 2013;66(3):216-21.

4.

Macrophage cholesterol depletion and its effect on the phagocytosis of Cryptococcus neoformans.

Bryan AM, Farnoud AM, Mor V, Del Poeta M.

J Vis Exp. 2014 Dec 19;(94). doi: 10.3791/52432.

5.

Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation.

Alvarez M, Saylor C, Casadevall A.

Cell Microbiol. 2008 Aug;10(8):1622-33. doi: 10.1111/j.1462-5822.2008.01152.x. Epub 2008 Apr 1.

8.

Influenza A Virus as a Predisposing Factor for Cryptococcosis.

Oliveira LVN, Costa MC, Magalhães TFF, Bastos RW, Santos PC, Carneiro HCS, Ribeiro NQ, Ferreira GF, Ribeiro LS, Gonçalves APF, Fagundes CT, Pascoal-Xavier MA, Djordjevic JT, Sorrell TC, Souza DG, Machado AMV, Santos DA.

Front Cell Infect Microbiol. 2017 Sep 26;7:419. doi: 10.3389/fcimb.2017.00419. eCollection 2017.

9.

Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, Bennett JE, Holland SM, Browne SK, Kwon-Chung KJ.

MBio. 2014 Mar 18;5(2):e00912-14. doi: 10.1128/mBio.00912-14.

10.

A murine model of Cryptococcus gattii meningoencephalitis.

Thompson GR 3rd, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR, Patterson TF.

J Antimicrob Chemother. 2012 Jun;67(6):1432-8. doi: 10.1093/jac/dks060. Epub 2012 Feb 29.

11.

Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Davis MJ, Eastman AJ, Qiu Y, Gregorka B, Kozel TR, Osterholzer JJ, Curtis JL, Swanson JA, Olszewski MA.

J Immunol. 2015 Mar 1;194(5):2219-31. doi: 10.4049/jimmunol.1402376. Epub 2015 Jan 30.

12.

Analysis of cell cycle and replication of mouse macrophages after in vivo and in vitro Cryptococcus neoformans infection using laser scanning cytometry.

Coelho C, Tesfa L, Zhang J, Rivera J, Gonçalves T, Casadevall A.

Infect Immun. 2012 Apr;80(4):1467-78. doi: 10.1128/IAI.06332-11. Epub 2012 Jan 17.

13.

Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.

Hansakon A, Mutthakalin P, Ngamskulrungroj P, Chayakulkeeree M, Angkasekwinai P.

Virulence. 2019 Dec;10(1):26-36. doi: 10.1080/21505594.2018.1556150.

14.

Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.

Goulart L, Rosa e Silva LK, Chiapello L, Silveira C, Crestani J, Masih D, Vainstein MH.

Med Mycol. 2010 Nov;48(7):932-41. doi: 10.3109/13693781003677494.

PMID:
20302549
15.

[Mechanism of Cryptococcus Meningoencephalitis].

Miyazato A.

Med Mycol J. 2016;57(1):J27-32. doi: 10.3314/mmj.57.J27. Review. Japanese.

16.

Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.

Capilla J, Maffei CM, Clemons KV, Sobel RA, Stevens DA.

Med Mycol. 2006 Nov;44(7):601-10.

PMID:
17071553
17.

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS.

Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a019760. doi: 10.1101/cshperspect.a019760. Review.

18.

Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.

Pereira de Sá N, Lino CI, Fonseca NC, Borelli BM, Ramos JP, Souza-Fagundes EM, Rosa CA, Santos DA, Barbosa de Oliveira R, Johann S.

Eur J Med Chem. 2015 Sep 18;102:233-42. doi: 10.1016/j.ejmech.2015.07.032. Epub 2015 Jul 17.

PMID:
26276437
19.

Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.

Andrade-Silva L, Ferreira-Paim K, Mora DJ, Da Silva PR, Andrade AA, Araujo NE, Pedrosa AL, Silva-Vergara ML.

Med Mycol. 2013 Aug;51(6):635-40. doi: 10.3109/13693786.2012.761737. Epub 2013 Jan 23.

PMID:
23343452
20.

Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.

Olave MC, Vargas-Zambrano JC, Celis AM, Castañeda E, González JM.

Mycoses. 2017 Jul;60(7):447-453. doi: 10.1111/myc.12619. Epub 2017 Mar 24.

PMID:
28338245

Supplemental Content

Support Center